Your browser doesn't support javascript.
loading
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
Crabb, Simon J; Griffiths, Gareth; Marwood, Ellice; Dunkley, Denise; Downs, Nichola; Martin, Karen; Light, Michelle; Northey, Josh; Wilding, Sam; Whitehead, Amy; Shaw, Emily; Birtle, Alison J; Bahl, Amit; Elliott, Tony; Westbury, Charlotte; Sundar, Santhanam; Robinson, Angus; Jagdev, Satinder; Kumar, Satish; Rooney, Claire; Salinas-Souza, Carolina; Stephens, Christine; Khoo, Vincent; Jones, Robert J.
Afiliação
  • Crabb SJ; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Griffiths G; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Marwood E; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom.
  • Dunkley D; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Downs N; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Martin K; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Light M; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Northey J; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Wilding S; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Whitehead A; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom.
  • Shaw E; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Birtle AJ; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Bahl A; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Elliott T; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Westbury C; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Sundar S; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Robinson A; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Jagdev S; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Kumar S; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Rooney C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Salinas-Souza C; Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
  • Stephens C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Khoo V; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Jones RJ; Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.
J Clin Oncol ; 39(3): 190-201, 2021 01 20.
Article em En | MEDLINE | ID: mdl-33326257
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pirimidinas / Pirróis / Prednisolona / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Próstata Resistentes à Castração / Docetaxel Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pirimidinas / Pirróis / Prednisolona / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Próstata Resistentes à Castração / Docetaxel Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article